跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
乐泰可 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Rimegepant Sulfate Orally Disintegrating Tablets
Approved
化学药品
Rimegepant Sulfate Orally Disintegrating Tablets
PFIZER INC.
🇨🇳 National Medical Products Administration
Approval Date
Jan 23, 2024
Approval ID
8WtlPdZ0jaV
Company
PFIZER INC.
Type
化学药品
Approval Details
Approval Id
8WtlPdZ0jaV
Approval Number
国药准字HJ20240004
Generic Name
硫酸瑞美吉泮口崩片
Generic Name En
Rimegepant Sulfate Orally Disintegrating Tablets
Trade Name
乐泰可
Drug Type
化学药品
Dosage Form
片剂
Strength
75mg(按 C₂₈H₂₈F₂N₆O₃计)
Reg Date
2024-01-23
Expired Date
2029-01-22
Company Name
PFIZER INC.
Production Company Name
CATALENT PHARMA SOLUTIONS LIMITED
Company Detail Path
/organization/pfizer-inc
Production Company Detail Path
/organization/catalent-pharma-solutions-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 23, 2024
Approval ID
8WtlPdZ0jaV
Type
化学药品
Back to NMPA Approvals